GC Wealth Management RIA, LLC

Position in LLY — ELI LILLY & Co

CIK 2011169 Cambridge, MA

Position in LLY

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$21,983,154

+$3,737,677 QoQ

Shares Held

18,328

-7.6% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.65%

of 13F equity value

Holder Rank

#847

of 4,605 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GC Wealth Management RIA, LLC holds $51,496,913 across 12 Drug Manufacturers - General names. LLY ranks #1 (42.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	18,328	$21,983,154
2	ABBV	AbbVie Inc.	37,102	$9,336,347
3	MRK	Merck & Co., Inc.	39,089	$5,022,936
4	JNJ	Johnson & Johnson	18,773	$4,767,778
5	AZN	Astrazeneca PLC	18,143	$3,440,275
6	AMGN	Amgen Inc	6,073	$2,199,154
7	NVO	Novo Nordisk A S	39,641	$1,900,389
8	NVS	Novartis AG	6,349	$995,015

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,983,154	18,328	-7.6%	Shares	Sole	2026-07-16
2026-03-31	$18,245,477	19,837	+1.0%	Shares	Sole	2026-05-14
2025-12-31	$21,112,090	19,645	-25.3%	Shares	Defined	2026-01-30
2025-09-30	$20,065,374	26,298	+119.3%	Shares	Sole	2025-11-13
2025-06-30	$9,348,903	11,993	+278.0%	Shares	Sole	2025-07-17
2025-03-31	$2,620,612	3,173	-2.2%	Shares	Sole	2025-05-12
2024-12-31	$2,504,368	3,244	-0.3%	Shares	Sole	2025-02-07
2024-09-30	$2,882,848	3,254	+2.3%	Shares	Sole	2024-11-04
2024-06-30	$2,879,108	3,180	-4.3%	Shares	Sole	2024-07-31
2024-03-31	$2,585,939	3,324	+36.8%	Shares	Sole	2024-05-10
2023-12-31	$1,415,912	2,429	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.